Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

NCT06621329 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06621329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06621329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
Lead sponsor
University of California, Davis
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 17, 2024
Completion date
October 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache, sah (subarachnoid hemorrhage)